sinc
beta
coronavirus
cov
caus
three
zoonot
outbreak
sarscov
merscov
newli
emerg
late
howev
littl
current
known
biolog
use
protein
pseudoviru
system
confirm
human
angiotensin
convert
enzym
receptor
find
enter
cell
mainli
endocytosi
pikfyv
cathepsin
l
critic
entri
protein
less
stabl
sarscov
polyclon
antisar
antibodi
inhibit
entri
sarscov
pseudovirion
studi
use
recov
sar
patient
sera
show
limit
crossneutr
suggest
recoveri
one
infect
might
protect
result
present
potenti
target
develop
drug
vaccin
wwwnaturecomnaturecommun
c
oronavirus
cov
infect
human
anim
caus
varieti
diseas
includ
respiratori
enter
renal
neurolog
diseas
classifi
four
genera
alphacov
betacov
gammacov
deltacov
sinc
begin
centuri
alreadi
three
zoonot
outbreak
betacov
sever
acut
respiratori
syndrom
coronaviru
sarscov
lineag
b
betacov
emerg
bat
palm
civet
infect
peopl
caus
death
middl
east
respiratori
syndrom
coronaviru
merscov
lineag
c
betacov
discov
caus
agent
sever
respiratori
syndrom
saudi
arabia
current
confirm
case
death
remain
endem
middl
east
dromedari
camel
consid
zoonot
reservoir
host
merscov
end
novel
coronaviru
name
found
patient
sever
pneumonia
wuhan
china
virus
isol
patient
sequenc
phylogenet
analysi
reveal
lineag
b
betacov
close
relat
sarslik
sl
cov
discov
cave
yunnan
china
share
nucleotid
sequenc
ident
suggest
might
emerg
bat
slcov
howev
intermedi
host
whether
intermedi
host
remain
determin
cov
use
spike
glycoprotein
main
target
neutral
antibodi
bind
receptor
mediat
membran
fusion
viru
entri
monom
trimer
protein
kda
contain
two
subunit
mediat
attach
membran
fusion
respect
structur
nand
ctermin
portion
fold
two
independ
domain
ntermin
domain
ntd
ctermin
domain
cdomain
fig
depend
viru
either
ntd
cdomain
serv
receptorbind
domain
rbd
rbd
mous
hepat
viru
mhv
locat
ntd
cov
includ
sarscov
merscov
use
cdomain
bind
receptor
mhv
use
mous
carcinoembryon
antigen
relat
cell
adhes
molecul
receptor
receptor
sarscov
merscov
human
angiotensinconvert
enzym
human
dipeptidyl
peptidas
respect
protein
share
amino
acid
ident
sarscov
respect
amino
acid
sequenc
potenti
rbd
homolog
respect
recent
zhou
et
al
report
use
receptor
cov
protein
typic
class
viral
fusion
protein
proteas
cleavag
requir
activ
fusion
potenti
protein
twostep
sequenti
proteas
cleavag
model
propos
activ
protein
sarscov
merscov
prime
cleavag
activ
cleavag
site
depend
viru
strain
cell
type
cov
protein
may
cleav
one
sever
host
proteas
includ
furin
trypsin
cathepsin
transmembran
proteas
serin
human
airway
trypsinlik
proteas
hat
avail
proteas
target
cell
larg
determin
whether
cov
enter
cell
plasma
membran
endocytosi
howev
whether
proteas
could
promot
viru
entri
remain
elus
studi
use
lentivir
pseudotyp
system
determin
cell
type
suscept
viru
receptor
entri
pathway
proteas
prime
identifi
sever
potenti
drug
target
demonstr
limit
crossneutr
convalesc
sera
sar
patient
express
protein
enhanc
express
protein
mammalian
cell
codonoptim
cdna
encod
protein
tag
synthes
facilit
incorpor
protein
lentivir
pseudoviron
last
amino
acid
contain
endoplasm
reticulum
er
retent
signal
cytoplasm
tail
protein
remov
fig
construct
name
cell
transfect
plasmid
express
protein
determin
western
blot
two
major
band
kda
kda
detect
mous
antiflag
antibodi
fig
lane
reflect
fulllength
cleav
protein
respect
band
kda
like
result
dimer
trimer
protein
consist
previou
report
merscov
protein
detect
polyclon
goat
antimhv
antibodi
fig
also
detect
sarscov
protein
suggest
presenc
conserv
immunogen
epitop
among
four
differ
cov
presum
linear
epitop
like
subunit
sarscov
share
almost
amino
acid
ident
nevertheless
protein
bare
detect
rabbit
polyclon
antisar
antibodi
fig
suggest
major
epitop
antibodi
includ
nonconserv
region
protein
detect
either
monoclon
antisar
antibodi
fig
antim
antibodi
fig
pseudovirion
incorpor
protein
effici
protein
incorpor
pseudovirion
evalu
use
monoclon
mous
antiflag
antibodi
polyclon
goat
antimhv
antibodi
major
sarscov
protein
incorpor
pseudoviron
fulllength
kda
fig
protein
lentivir
pseudovirion
cleav
kda
fig
h
like
reflect
presenc
extra
furin
site
fig
protein
consist
result
cell
lysat
fig
sarscov
protein
protein
pseudovirion
readili
detect
use
polyclon
rabbit
antisar
antibodi
fig
human
receptor
next
determin
whether
pseudovirion
abl
transduc
human
monkey
bat
cell
vsvg
pseudoviron
use
posit
control
wherea
bald
particl
spike
protein
mock
serv
neg
control
expect
cell
type
effect
transduc
vsvg
pseudoviron
fig
compar
mock
control
pseudovirion
show
increas
luciferas
activ
cell
level
similar
sarscov
pseudovirion
fig
vero
cell
also
gave
increas
luciferas
activ
transduc
transduct
cell
higher
sarscov
pseudovirion
pseudovirion
fig
suggest
might
differ
viru
entri
cell
mediat
protein
sarscov
investig
whether
known
cov
receptor
might
use
protein
entri
receptor
pseudoviron
use
transduc
bhk
cell
stabli
express
human
aminopeptidas
n
hapn
receptor
human
cov
cell
stabli
express
receptor
sarscov
hela
cell
stabli
express
receptor
merscov
bhkhapn
cell
suscept
transduct
pseudovirion
cell
highli
transduc
pseudovirion
consist
receptor
determin
whether
protein
could
directli
bind
protein
hek
cell
transient
express
protein
incub
solubl
analyz
flow
cytometri
shown
fig
protein
bound
solubl
level
similar
sarscov
protein
although
mean
fluoresc
intens
mfi
protein
slightli
lower
sarscov
protein
investig
receptor
perform
inhibit
experi
use
solubl
solubl
protein
preincub
pseudoviron
ice
h
virusprotein
mixtur
ad
onto
cell
entri
pseudovirion
significantli
prevent
preincub
solubl
fig
support
notion
receptor
solubl
might
use
therapeut
inhibitor
infect
enter
cell
endocytosi
major
protein
pseudovirion
cleav
fig
h
next
determin
whether
pseudoviron
enter
cell
endocytosi
cell
surfac
hek
cell
treat
lysosomotrop
agent
ammonia
chlorid
bafilomycin
effect
viru
entri
evalu
consist
previou
report
mm
nh
cl
nm
bafilomycin
decreas
entri
sarscov
vsvg
pseudovirion
compar
treatment
control
reduct
transduct
cell
pseudovirion
also
shown
cell
incub
either
nh
cl
bafilomycin
fig
indic
pseudovirion
enter
cell
mainli
endocytosi
despit
spike
protein
cleav
pikfyv
critic
entri
phosphoinositid
play
mani
essenti
role
endocytosi
among
one
pi
p
regul
earli
endosom
late
endosom
dynam
phosphatidylinositol
pikfyv
main
enzym
synthes
pi
p
earli
endosom
hek
cell
treat
apilimod
potent
inhibitor
pikfyv
monoclon
antisar
polyclon
antisar
polyclon
antisar
polyclon
antimhv
antiflag
natur
commun
http
articl
natur
commun
http
wwwnaturecomnaturecommun
depend
manner
fig
wherea
effect
entri
vsvg
pseudovirion
occur
earli
endosom
similar
inhibitori
effect
observ
cell
hela
cell
stabli
express
mous
carcinoembryon
antigen
relat
cell
adhes
molecul
treat
apilimod
transduc
merscov
mhv
pseudovirion
fig
respect
moreov
infect
live
mhv
cell
also
strongli
inhibit
apilimod
treatment
fig
signific
cell
toxic
observ
apilimod
concentr
test
fig
determin
whether
apilimod
could
inhibit
entri
pseudovirion
expect
apilimod
treatment
inhibit
entri
pseudovirion
dose
depend
manner
fig
similar
effect
shown
cell
treat
anoth
pikfyv
inhibitor
fig
result
suggest
pikfyv
might
potenti
gener
drug
target
virus
enter
cell
endocytosi
two
pore
channel
subtyp
lysosom
two
major
downstream
effector
pi
p
block
activ
tetrandrin
inhibitor
decreas
entri
pseudovirion
fig
treatment
cell
inhibitor
effect
supplementari
fig
indic
import
entri
effect
cathepsin
inhibitor
entri
proteas
activ
protein
import
step
coronaviru
entri
cathepsin
lysosom
shown
critic
sarscov
merscov
entri
endocytosi
investig
whether
cathepsin
requir
entri
hek
cell
treat
either
broad
inhibitor
cathepsin
b
h
l
calpain
cathepsin
l
inhibitor
sid
cathepsin
b
inhibitor
vsvg
pseudovirion
use
neg
control
sinc
viru
entri
mediat
vsvg
requir
proteas
activ
treatment
cell
reduc
entri
pseudovirion
indic
least
one
cathepsin
calpain
might
requir
entri
fig
cathepsin
b
inhibitor
treatment
show
mark
effect
viru
entri
cathepsin
l
inhibit
treatment
decreas
entri
pseudovirion
fig
suggest
cathepsin
l
essenti
prime
protein
lysosom
entri
cell
cellcel
fusion
mediat
protein
type
ii
membran
serin
proteas
tmprss
mediat
cleavag
activ
fusion
potenti
sarscov
merscov
protein
induc
receptordepend
syncytium
format
test
whether
protein
cleav
cellular
proteas
could
trigger
syncytium
format
overlaid
hek
cell
express
control
protein
cell
presenc
absenc
proteas
express
tmprss
cell
enhanc
proteinmedi
cellcel
fusion
similarli
sasrcov
supplementari
fig
next
evalu
role
trypsin
consist
previou
report
addit
trypsin
trigger
syncytium
format
cell
sarscov
protein
h
incub
fig
c
larg
syncytia
form
level
similar
sarscov
protein
protein
express
cell
ad
onto
cell
trypsin
note
sarscov
protein
induc
syncytia
format
cell
even
absenc
trypsin
fig
suggest
protein
could
trigger
upon
receptor
bind
without
exogen
proteas
prime
activ
ebola
viru
outbreak
mutat
glycoprotein
gp
ebola
viru
link
increas
viru
transmiss
studi
show
mutat
decreas
thermost
gp
increas
viru
infect
cell
cultur
investig
thermost
protein
compar
sarscov
protein
protein
less
stabl
requir
signific
shorter
time
lower
temperatur
inactiv
fig
e
nativ
protein
metast
energi
barrier
prevent
undergo
conform
chang
trigger
protein
might
decreas
energi
barrier
reduc
thermost
might
contribut
hightransmiss
effici
effect
antisar
antibodi
protein
sinc
react
weakli
polyclon
rabbit
antisar
antibodi
western
blot
fig
investig
whether
protein
nativ
conform
could
recogn
antisar
antibodi
cell
transient
express
protein
incub
polyclon
antisar
antibodi
analyz
flow
cytometri
sarscov
use
posit
control
expect
express
sarscov
protein
cell
surfac
readili
detect
polyclon
antisar
antibodi
fig
contrast
low
level
bind
protein
polyclon
rabbit
antisar
antibodi
detect
fig
delin
conform
epitop
polyclon
antibodi
locat
two
new
construct
gener
sarscov
protein
backbon
rbd
sarscov
snrbd
protein
backbon
rbd
sarscov
ssrbd
replac
sarscov
rbd
rbd
sarscov
snrbd
decreas
bind
polyclon
antibodi
protein
wherea
substitut
rbd
sarscov
rbd
ssrbd
increas
affin
protein
polyclon
antibodi
fig
chimera
protein
express
level
similar
protein
fig
top
panel
result
suggest
least
one
major
conform
epitop
polyclon
antibodi
might
locat
rbd
sequenc
differ
sarscov
fig
note
ssrbd
bound
polyclon
antibodi
better
sarscov
snrbd
flow
cytometri
signal
sarscov
snrbd
stronger
ssrbd
western
blot
polyclon
antibodi
indic
major
linear
epitop
polyclon
antibodi
locat
sarscov
ntd
among
residu
sarscov
rbd
critic
receptor
bind
viru
entri
seven
differ
sarscov
rbd
fig
mutat
sarscov
protein
correspond
residu
except
sarscov
mutant
reduc
protein
express
supplementari
fig
bind
sarscov
mutant
polyclon
rabbit
antisar
antibodi
affect
fig
suggest
residu
might
direct
bind
site
polyclon
antibodi
next
test
whether
polyclon
rabbit
antisar
antibodi
could
inhibit
entri
pseudovirion
cov
protein
pseudovirion
incub
polyclon
antibodi
ice
h
transduct
measur
accord
luciferas
activ
expect
polyclon
antibodi
neutral
sarscov
pseudovirion
effect
dose
depend
manner
fig
contrast
even
concentr
polyclon
antibodi
mark
effect
transduct
protein
fig
crossneutr
sar
patient
sera
rabbit
polyclon
antisar
antibodi
show
signific
neutral
activ
pseudovirion
ask
whether
sera
recov
sar
patient
could
neutral
sarscov
pseudovirion
obtain
sera
one
recov
sar
patient
five
recov
patient
test
neutral
activ
transduct
cell
sarscov
pseudovirion
serum
recov
sar
patient
show
strong
inhibit
transduct
sarscov
pseudovirion
modest
neutral
activ
pseudoviron
fig
tabl
contrast
sera
five
patient
neutral
pseudovirion
effect
none
effect
transduct
sarscov
pseudovirion
fig
tabl
discuss
emerg
pathogen
infect
human
origin
anim
cov
among
forefront
pathogen
newli
emerg
infect
human
caus
sever
pneumonia
februari
current
outbreak
spread
countri
confirm
case
death
howev
littl
known
biolog
sinc
viru
categor
biosafeti
level
agent
accord
guidelin
develop
pseudotyp
system
protein
studi
viru
entri
set
understand
enter
cell
provid
valuabl
inform
viru
pathogenesi
vaccin
design
drug
target
polyclon
antisar
antibodi
util
pseudotyp
system
screen
panel
human
monkey
cell
line
suscept
smediat
transduct
line
caus
respiratori
infect
human
found
human
lung
cancer
cell
line
highli
suscept
smediat
entri
cell
rhesu
monkey
kidney
epithelium
cell
line
exhibit
differ
suscept
sarscov
transduct
reason
current
known
requir
investig
protein
use
receptor
bind
entri
confirm
flow
cytometri
analysi
competit
inhibit
experi
use
solubl
studi
fig
c
fulllength
protein
sarscov
share
almost
ident
amino
acid
sequenc
ntd
show
homolog
note
ntd
differ
cov
protein
shown
bind
differ
sugar
ntd
merscov
prefer
sialic
acid
sialic
acid
ntd
human
cov
bind
sialic
acid
sugar
bind
report
ntd
sarscov
whether
ntd
bind
sugar
whether
sugar
bind
ntd
affect
viru
entri
remain
determin
success
conform
chang
protein
lead
membran
fusion
requir
receptor
bind
also
need
appropri
proteas
activ
furin
site
amino
acid
rrar
subunit
protein
similar
happen
highpathogen
influenza
virus
whether
presenc
furin
site
effect
viral
pathogenesi
viru
spread
among
human
remain
determin
although
major
protein
pseuodvirion
cleav
endocytosi
main
entri
pathway
cell
experi
lysosom
cathepsin
l
b
appear
critic
protein
activ
similar
report
sarscov
merscov
trypsin
could
also
activ
protein
effici
induc
larg
syncytium
format
surpris
found
even
without
trypsin
protein
could
trigger
syncytium
format
cell
phenomena
similar
fig
character
polyclon
rabbit
antisar
antibodi
bind
polyclon
rabbit
antisar
antibodi
sarscov
chimer
protein
cell
transient
express
either
sarscov
sarscov
snrbd
srbd
protein
incub
polyclon
rabbit
antisarscov
antibodi
h
ice
follow
fitcconjug
secondari
antibodi
cell
analyz
flow
cytometri
experi
done
three
time
one
repres
shown
b
express
sarscov
chimer
protein
cell
cell
panel
lyze
blot
antiflag
antibodi
polyclon
antisar
antibodi
c
amino
acid
sequenc
align
sarscov
rbd
star
indic
seven
critic
residu
differ
sarscov
rbd
bind
polyclon
rabbit
antisar
antibodi
mutant
sarscov
protein
e
neutral
sarscov
pseudovirion
polyclon
rabbit
antisar
antibodi
pseudoviron
preincub
serial
dilut
polyclon
rabbit
antisar
antibodi
ice
virusantibodi
mixtur
ad
cell
pseudovir
transduct
measur
h
later
experi
done
triplic
repeat
twice
one
repres
shown
error
bar
indic
sem
technic
triplic
sourc
data
provid
sourc
data
file
sarscov
pseudovirion
preincub
serial
dilut
patient
sera
h
ice
virusantibodi
mixtur
ad
cell
cell
lyse
h
later
pseudoviru
transduct
measur
highest
dilut
serum
sampl
decreas
transduct
consid
posit
sourc
data
provid
sourc
data
file
observ
mhv
protein
certain
aspect
led
us
specul
protein
capabl
trigger
proteaseindepend
receptordepend
syncytium
format
mechan
might
enhanc
viru
spread
cellcel
fusion
might
partial
explain
rapid
progress
diseas
howev
exclud
potenti
role
endogen
proteas
cell
syncytium
format
also
evalu
entri
cell
type
requir
research
recent
studi
show
earli
late
endosom
matur
regul
pi
p
inhibit
pikfyv
key
enzym
synthes
pi
p
downstream
effector
lysosom
significantli
reduc
viru
entri
merscov
confirm
studi
show
block
pikfyv
also
strongli
inhibit
entri
mediat
protein
indic
pi
p
pathway
might
consid
potenti
gener
drug
target
cov
infect
cov
protein
one
key
compon
determin
viru
virul
tissu
tropism
host
rang
also
main
target
neutral
antibodi
vaccin
design
although
protein
sarscov
highli
homolog
polyclon
rabbit
antisar
antibodi
bind
protein
well
poorli
neutral
proteinmedi
viru
entri
analysi
reveal
major
immuneepitop
antibodi
like
lie
region
rbd
fig
evalu
crossneutr
sarscov
use
convalesc
sera
sar
patient
saw
moder
crossneutr
activ
sarscov
convalesc
sera
suggest
previous
recov
sarscov
infect
may
fulli
protect
infect
vice
versa
manuscript
review
hoffmann
et
al
report
human
entri
receptor
serin
proteas
import
activ
consist
find
agreement
work
sera
convalesc
sar
patient
neutral
pseudovirion
entri
lower
effici
sarscov
pseudovirion
entri
show
moder
crossneutr
conclus
demonstr
protein
entri
cell
mainli
mediat
endocytosi
pikfyv
cathepsin
l
critic
viru
entri
found
protein
could
trigger
syncytia
cell
independ
exogen
proteas
final
limit
crossneutr
activ
convalesc
sera
sar
patient
find
provid
potenti
target
develop
drug
vaccin
newli
emerg
lineag
b
betacov
construct
plasmid
codonoptim
cdna
sequenc
shown
supplementari
tabl
encod
glycoprotein
ctermin
amino
acid
delet
synthes
clone
eukaryot
cell
express
vector
hind
iii
bamh
site
plasmid
encod
sarscov
glycoprotein
merscov
glycoprotein
mhv
glycoprotein
sequenc
shown
supplementari
tabl
construct
insert
dna
fragment
encod
codonoptim
sarscov
protein
lack
last
amino
acid
aa
merscov
protein
lack
last
aa
flag
tag
c
terminu
fulllength
mhv
protein
bamh
site
respect
vsvg
encod
plasmid
lentivir
packag
plasmid
obtain
addgen
cambridg
plentigfp
lentivir
report
plasmid
express
gfp
luciferas
gener
gift
fang
li
duke
univers
primer
use
studi
list
supplementari
tabl
product
pseudovirion
viru
entri
pseudovirion
produc
cotransfect
cell
plentigfp
plasmid
encod
either
sarscov
vsvg
empti
vector
use
polyetherimid
pei
supernat
harvest
h
post
transfect
pass
filter
centrifug
g
min
remov
cell
debri
transduc
cell
pseudovirion
cell
seed
plate
inocul
media
contain
pseudovirion
overnight
incub
cell
fed
fresh
media
h
post
inocul
cell
lyse
medium
contain
steadyglo
promega
room
temperatur
min
transduct
effici
measur
quantif
luciferas
activ
use
modulu
ii
micropl
reader
turner
biosystem
sunnyval
ca
usa
experi
done
triplic
repeat
least
twice
detect
protein
western
blot
spike
glycoprotein
cell
pseudovirion
detect
use
western
blot
briefli
cell
transfect
plasmid
encod
spike
glycoprotein
sarscov
merscov
mhv
lyse
h
post
transfect
ripa
buffer
mm
trishcl
ph
mm
nacl
mm
edta
sd
inhibitor
cocktail
pellet
pseudovirion
viral
supernat
centrifug
rpm
h
beckman
rotor
sucros
cushion
viru
pellet
resuspend
ripa
buffer
sampl
boil
min
separ
sdspage
gel
transfer
nitrocellulos
filter
membran
block
milk
membran
blot
primari
antibodi
follow
incub
horseradish
peroxidas
hrp
conjug
secondari
antibodi
visual
chemiluminesc
reagent
biorad
mhv
protein
detect
use
polyclon
goat
antimhv
antibodi
sarscov
protein
blot
either
polyclon
antisar
antibodi
sinobiolog
inc
beij
china
mous
monoclon
sar
antibodi
sinobiolog
inc
beij
china
merscov
protein
detect
use
mous
monoclon
antim
sinobiolog
inc
beij
china
antiflag
antibodi
sigma
st
loui
mo
usa
respect
effect
agent
inhibitor
pseudovirion
entri
hek
cell
pretreat
either
lysosomotrop
agent
endosom
acidif
inhibitor
nh
cl
bafilomycin
pikfyv
inhibitor
apilimod
calcium
channel
blocker
tetrandrin
cathepsin
inhibitor
cathepsin
l
inhibitor
cathepsin
b
inhibitor
cathepsin
inhibitor
h
spininocul
pseudovirion
presenc
inhibitor
g
min
overnight
incub
cell
fed
fresh
medium
without
inhibitor
cell
lyse
h
post
inocul
luciferas
activ
measur
flow
cytometr
analysi
protein
express
briefli
cell
transfect
plasmid
encod
either
sarscov
merscov
protein
use
pei
forti
hour
later
cell
detach
use
pb
mm
edta
wash
cell
incub
polyclon
rabbit
antisar
antibodi
dilut
sinobiolog
inc
beij
china
h
ice
follow
alexa
fluor
goat
antirabbit
igg
zsgbbio
llc
beij
china
h
cell
analyz
flow
cytometri
mtt
assay
mtt
assay
use
assess
cell
viabil
briefli
cell
seed
plate
cell
densiti
per
well
allow
adher
h
follow
treatment
serial
dilut
inhibitor
h
two
microlit
mgml
mtt
ad
medium
h
later
incub
h
remov
cultur
medium
dmso
ad
absorb
measur
nm
use
micropl
spectrophotomet
multiskan
fc
thermo
scientif
experi
perform
triplic
cell
viabil
cell
calcul
ratio
experiment
condit
control
cellcel
fusion
assay
cell
cotransfect
plasmid
encod
cov
glycoprotein
egfp
trypsindepend
cellcel
fusion
cell
detach
trypsin
h
post
transfect
overlaid
confluent
monolay
cell
ratio
approxim
one
sexpress
cell
three
receptorexpress
cell
trypsinindepend
cellcel
fusion
cell
detach
mm
edta
overlaid
cell
h
incub
imag
syncytia
captur
nikon
epifluoresc
microscop
run
metamorph
softwar
molecular
devic
experi
done
triplic
repeat
least
three
time
express
purif
solubl
human
dna
fragment
encod
residu
human
ntermin
flag
tag
clone
sal
hind
iii
modifi
vector
signal
peptid
solubl
receptor
express
high
five
insect
cell
use
bactobac
system
invitrogen
purifi
use
nickel
affin
ionexchang
chromatographi
solubl
assay
cell
transfect
plasmid
encod
sarscov
merscov
protein
cell
detach
mm
edta
h
post
transfect
wash
twice
fb
incub
solubl
h
ice
wash
three
time
fb
cell
incub
polyclon
goat
antihuman
antibodi
r
system
mn
usa
h
follow
fitcconjug
rabbit
antigoat
secondari
antibodi
jackson
immunoresearch
pa
usa
wash
cell
analyz
flow
cytometri
solubl
inhibit
assay
briefli
lentivirus
pseudotyp
sarscov
vsvg
preincub
serial
dilut
solubl
h
ice
mixtur
ad
cell
follow
centrifug
inocul
h
room
temperatur
cell
fed
fresh
medium
h
later
lyse
h
post
inocul
pseudovir
transduct
measur
accord
luciferas
activ
pseudoviru
neutral
assay
sarscov
vsvg
pseudovirion
preincub
serial
dilut
either
polyclon
rabbit
antisar
antibodi
patient
sera
h
ice
virusantibodi
mixtur
ad
onto
cell
plate
h
incub
inoculum
replac
fresh
medium
cell
lyse
h
later
pseudoviru
transduct
measur
previous
describ
prior
experi
patient
sera
incub
min
inactiv
complement
serum
collect
five
patient
hospit
pneumonia
hengshui
third
peopl
hospit
hengshui
heibei
provinc
china
respiratori
specimen
collect
coronaviru
detect
posit
patient
recov
sera
collect
right
discharg
inform
consent
serum
recov
sar
patient
also
collect
two
year
recoveri
inform
consent
report
summari
inform
research
design
avail
natur
research
report
summari
link
articl
data
support
find
studi
avail
author
upon
request
sourc
data
underli
fig
b
ce
e
b
tabl
supplementari
fig
provid
sourc
data
file
receiv
februari
accept
march
